Literature DB >> 22116945

Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study.

C Helmer1, B Stengel, M Metzger, M Froissart, Z-A Massy, C Tzourio, C Berr, J-F Dartigues.   

Abstract

OBJECTIVE: To evaluate the longitudinal relationship between moderate chronic kidney disease (CKD), decline in kidney function, and microalbuminuria with subsequent cognitive decline and incident dementia.
METHODS: This study is based on a population-based cohort of 7,839 subjects over 65 years with 7 years of follow-up. Glomerular filtration rate was estimated (eGFR) using the CKD-EPI equation. Global cognitive function was assessed using the Mini-Mental State Examination (MMSE) and dementia was actively screened and diagnosed.
RESULTS: At baseline, 12% of the participants had an eGFR <60 mL/min/1.73 m(2). A total of 564 incident dementia cases were diagnosed during the follow-up. Low baseline eGFR values were not associated with an increased risk of incident dementia or cognitive decline over the 7-year follow-up, except a borderline significant association with dementia with vascular component. However, eGFR decline over the first 4-year period was associated with higher risk of dementia with vascular component (relative risk = 5.35 [1.76-16.3] in those with eGFR decline >4 mL/min/1.73 m(2)/y compared with those <4) and with higher cognitive decline on the MMSE (-0.12 points, p < 0.01 in those with eGFR >4 mL/min/1.73 m(2)/y compared with those <4) in the 3 subsequent years. Proteinuria tended to be associated with an increased risk of subsequent dementia with vascular component.
CONCLUSIONS: Despite a large sample and a long follow-up, we found no increased risk of cognitive decline or dementia associated with low eGFR level. However, faster eGFR decline was associated with global cognitive decline and incident dementia with vascular component, suggesting that this association may be mediated by vascular mechanisms.

Entities:  

Mesh:

Year:  2011        PMID: 22116945     DOI: 10.1212/WNL.0b013e31823b4765

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  70 in total

1.  Albuminuria and cognitive decline in people with diabetes and normal renal function.

Authors:  Joshua I Barzilay; James F Lovato; Anne M Murray; Jeff Williamson; Faramaz Ismail-Beigi; Diane Karl; Vasilios Papademetriou; Lenore J Launer
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

2.  Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.

Authors:  Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-02-26       Impact factor: 5.992

Review 3.  Aging and chronic kidney disease: the impact on physical function and cognition.

Authors:  Shuchi Anand; Kirsten L Johansen; Manjula Kurella Tamura
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-02       Impact factor: 6.053

4.  Association between renal function and cognitive ability domains in the Einstein aging study: a cross-sectional analysis.

Authors:  Andrea R Zammit; Mindy J Katz; Jennifer Y Lai; Molly E Zimmerman; Markus Bitzer; Richard B Lipton
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-11-13       Impact factor: 6.053

Review 5.  The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review.

Authors:  Mary Hannan; Alana Steffen; Lauretta Quinn; Eileen G Collins; Shane A Phillips; Ulf G Bronas
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

Review 6.  Kidney disease and cognitive function.

Authors:  Merrill F Elias; Gregory A Dore; Adam Davey
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

7.  Kidney function and cognitive health in older adults: the Cardiovascular Health Study.

Authors:  Brendan Darsie; Michael G Shlipak; Mark J Sarnak; Ronit Katz; Annette L Fitzpatrick; Michelle C Odden
Journal:  Am J Epidemiol       Date:  2014-05-20       Impact factor: 4.897

8.  Brain Magnetic Resonance Imaging Findings in Children and Young Adults With CKD.

Authors:  Erum A Hartung; Guray Erus; Abbas F Jawad; Nina Laney; Jimit J Doshi; Stephen R Hooper; Jerilynn Radcliffe; Christos Davatzikos; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2018-02-15       Impact factor: 8.860

9.  Cognitive Impairment and Progression of CKD.

Authors:  Manjula Kurella Tamura; Kristine Yaffe; Chi-Yuan Hsu; Jingrong Yang; Stephen Sozio; Michael Fischer; Jing Chen; Akinlolu Ojo; Jennifer DeLuca; Dawei Xie; Eric Vittinghoff; Alan S Go
Journal:  Am J Kidney Dis       Date:  2016-03-10       Impact factor: 8.860

10.  Kidney Function and Cerebral Blood Flow: The Rotterdam Study.

Authors:  Sanaz Sedaghat; Meike W Vernooij; Elizabeth Loehrer; Francesco U S Mattace-Raso; Albert Hofman; Aad van der Lugt; Oscar H Franco; Abbas Dehghan; M Arfan Ikram
Journal:  J Am Soc Nephrol       Date:  2015-08-06       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.